45
I I Diabetes and Heart: Insight by Imaging Juhani Knuuti Turku PET Centre, Turku University Central Hospital II I Development and Application of Beta-Amyloid Imaging Agents Chet A. Mathis Department of Radiology, University of Pittsburgh PET Facility III I Molecular Genetic Imaging Using Nuclear Medicine Techniques June-Key Chung Department of Nuclear Medicine, Cancer Research Institute, Seoul National University College of Medicine I PET Radiation Protection -How much do we really need? Melvyn J. Myers Hammersmith Imanet Ltd., Hammersmith Hospital I PET PET 1 PET 2 S27
3 4 5 6 I II I-131 1 Surgical Management of Hyperthyroidism 2 3 I-131 4 5 131 I : II II viability 1 Key Note Lecture Myocardial Viability: Where are we now? Juhani Knuuti Turku PET Centre, Turku University Central Hospital 2 S28
3 SPECT/PET viability University of Ottawa Heart Institute 4 viability 5 MRI III I PET 1 FDG-PET FDG-PET 280 2 3 PET IV I PET 1 PET 2 PET 3PET, PET/CT 4 PET S29
V I 1 2 3 4 RDRC Phase 0 I II 1 2 3 4 5 Current Role of Nuclear Neuroimaging Studies in Korea Myung-Chul Lee Department of Nuclear Medicine, Seoul National University Hospital S30
II III PET/CT SPECT/CT 1 PET/CT VOLUME FUSION GE 2 PET/CT PET 3 SPECT/CT 4 SPECT/CT III I FDG PET 1 C-11 2 11 C 3 11 C-Choline 4 11 C-Acetate PET 5 F-18 FLT 6 FLT-PET 7 18 F FRP-170 S31
II 1 2 CAD IV Nuclear Oncology Peter S. Conti University of Southern California Key Note Lecture Peter S. Conti University of Southern California 8 p.s161 V Nuclear Cardiology Frank M. Bengel Nuklearmedizinische Klinik der TU München Key Note Lecture Cardiovascular Molecular Imaging: From Gene Expression to Physiologic Function Frank M. Bengel Nuklearmedizinische Klinik der TU München 8 p.s162 S32
VI Nuclear Neurology Myung-Chul Lee Seoul National University College of Medicine Department of Radiology, University of Washington Key Note Lecture Functional Brain Imaging: Past, Present, and Future Department of Radiology, University of Washington 8 p.s200 I 45 1 2 PET II II cost-benefit analysis S33
II 201 Tl / 67 Ga SPECT II SPECT II :EBM II I-131 RI II II Renography JR S34
I I SPECT PET/CT 1 PET/CT 2 II II SPECT PET/CT 1 2 II 1 DPC 2 FDG-PET 3 S35
45PET III PET PET 1 2 PET 3 FDG-PET 4 PET III 1 18 F-FDG Accumulation in Atherosclerotic Plaques: Immunohistochemical and PET Imaging Study 2 Central Effects of Fexofenadine and Cetirizine: Measurement of Psychomotor Performance, Subjective Sleepiness, and Brain Histamine H 1 -receptor Occupancy using 11 C-doxepin Positron Emission Tomography 3 A New Reconstruction Strategy for Image Improvement in Pinhole SPECT S36
V PET, SPECT 1 2 3 4 5 GE PET 1 PET 2 PET 3 PET S37
I III FDG-PET II IV FDG-PET 1 PET PET 2 Experiences of PET Oncology in Seoul National University Hospital June-Key Chung Department of Nuclear Medicine, Seoul National University Hospital III V Perfusion imaging 1 CE-MSCT imaging 2 SPECT imaging IV III Monitoring Anti-Amyloid Drug Trials with Pittsburgh Compound B Chet A. Mathis Departments of Radiology, Pharmacology and Pharmaceutical Sciences, University of Pittsburgh PET Facility S38
V IV Peaceful study Part 1 Part 2 VI V GSO PET-CT 1 Clinical Performance of the Philips Gemini GXL PET/CT System in Oncology Piotr Maniawski PHILIPS Medical Systems, Senior Marketing Manager 2 Zr GSO VII VI PET/CT 1 PET/CT 2 PET-CT S39
I I 1FDG-PET 2 PET PET/CT GE II II Hybrid Imaging 1 Prospects of PET/CT in Cardiology Frank M. Bengel Clinic of Nuclear Medicine, TU Muenchen 2 SPECT/Spiral-CT Hybrid Imaging : A Faster Way to a More Reliable Diagnosis Wolfgang Romer Clinic of Nuclear Medicine, University Hospital Erlangen III III S40
III IV RI 1 2 3 4 DES : SPECT C S41
V 1 PET 1 2 1 RI 2 2 3 VII 1. 2005 5 2005 10 2. I PIOPED S42
3. II II 1 Molecular Nuclear Medicine Peter S. Conti 2 Molecular Imaging : Definituion and Clinical Application F. David Rollo Philips Medical Systems 3 4 5 S43
IV 1 22 2 3 4 IHE 5IHE-J CD-ROM GE S44